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E-cadherinAlthough δ-cateninwasﬁrst considered as a brain speciﬁc protein, strong evidence of δ-catenin overexpression in
various cancers, including prostate cancer, has been accumulated. Phosphorylation of δ-catenin by Akt and
GSK3β has been studied in various cell lines. However, tyrosine phosphorylation of δ-catenin in prostate cancer
cells remains unknown. In the current study, we demonstrated that Src kinase itself phosphorylates δ-catenin on
its tyrosine residues in prostate cancer cells and further illustrated that Y1073, Y1112 and Y1176 of δ-catenin are
predominant sites responsible for tyrosine phosphorylationmediated by c-Src. Apart from c-Src, other Src family
kinases, including Fgr, Fyn and Lyn, can also phosphorylate δ-catenin. We also found that c-Src-mediated
Tyr-phosphorylation of δ-catenin increases its stability via decreasing its afﬁnity to GSK3β and enhances its
ability of inducing nuclear distribution of β-catenin through interrupting the integrity of the E-cadherin. Taken
together, these results indicate that c-Src can enhance the oncogenic function of δ-catenin inprostate cancer cells.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Src family kinases (SFKs) are the largest family of nonreceptor pro-
tein tyrosine kinases and responsible for signal transduction during
many cellular activities [1]. All SFK members share similar structures.
Each kinase composes of four Src homology (SH) domains and a unique
amino-terminal domain. On the basis of overall homology, SFKs can be
classiﬁed into two subfamilies. One is the Src subfamily including
Src, Yes, Fyn and Fgr. The other is the Lyn subfamily containing Lyn,
Hck, Lck and Blk. In addition, there are three SFK related kinases, Brk,
Frk, and Srm [2]. Among these kinases, Src, Fyn and Yes are ubiquitously
expressed in all cells while other members are tissue speciﬁc. As the
most wildly studied kinase among SFKs, Src has been implicated in a
variety of malignancies [3], including prostate cancer [4]. Other than Src,
Fgr [5] and Lyn [6] have also been found to be involved in prostate cancer.
Src has been proven to provide oncogenic signals for cell survival,
mitogenesis, epithelial-mesenchymal transition (EMT), invasion, angio-
genesis, and metastasis [7]. It has also been known to interact with
p120catenin (p120ctn) which was originally identiﬁed as a major sub-
strate of oncogene v-Src and as an important regulator of cadherin–
catenin complex mediating cell–cell adhesion [8]. So far, 8 tyrosine sitesResearch Institute for Drug
uth Korea.
ights reserved.on p120ctn have been identiﬁed to be phosphorylated by Src [9]. Howev-
er, the functional consequences of each speciﬁc modiﬁcation are not yet
clear. Although it has been found that the differential phosphorylation
of tyrosine 112, 217 and 228 by Fyn and Src kinasesmodulates the ability
of p120ctn to bind and inhibit Rho A [10], it is not fully known how Src-
induced p120ctn-phosphoylation modiﬁes cadherin functions.
δ-catenin is a member of the p120ctn subfamily of armadillo pro-
teins and was ﬁrst identiﬁed through its interaction with presenilin-1
[11]. Although δ-catenin was ﬁrst considered as a brain speciﬁc protein,
lately, its overexpression has been discovered in a variety of cancer tis-
sues, including prostate [12–14], lung [15–18], ovarian [19], brain [20]
and colorectal tumors [21]. Furthermore, strong evidence of δ-catenin
overexpression has been accumulated in prostate cancer. It has been re-
ported that δ-catenin is overexpressed at bothmRNA and protein levels
in prostate cancer [12,13]. It has also been demonstrated that δ-catenin
is accumulated in theurine of prostate cancer patients [14]. The function
of overexpressed δ-catenin in prostate cancer has been extensively
studied. It has been reported that δ-catenin promotes prostate cancer
cell growth and progression by altering the cell cycle and proﬁles of sur-
vival genes [22]. In our previous study, we found that δ-catenin induces
E-cadherin processing and activates the β-catenin signaling pathway in
prostate cancer [23]. We also demonstrated that δ-catenin promotes
angiogenesis through stabilizing HIF-1α to activate VEGF in the
CWR22Rv-1 prostate cancer cell line [24]. These studies suggest the
important role of δ-catenin in prostate cancer. However, δ-catenin has
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growth through siRNA-based genetic screening of human mammary
epithelial cells [25]. These contrary observations led us to question if
modiﬁcation of δ-catenin, especially tyrosine phosphorylation, can
change its biological functions.
Unlike p120ctn, there have been only few studies about tyrosine
phosphorylation of δ-catenin since it is a relatively new member in the
p120ctn subfamily of armadillo proteins. Lu et al. found that δ-catenin
can be phosphorylated on Y289 and Y429 by Abl kinase [26]. Maria
CM et al. discovered that δ-catenin can interact with the SH3 domain
of both Fyn and Lck and be phosphorylated by Fyn at its C-terminus
[27]. They also reported that tyrosine phosphorylation of δ-catenin can
mediate switching of its role between inducing neurite elongation and
inducing neurite branching. Although the overexpression of δ-catenin
in prostate cancer has been proven, whether tyrosine phosphorylation
of δ-catenin occurs in prostate cancer cells remains unknown.
Therefore, in this study, we demonstrated that Src kinase itself
phosphorylates δ-catenin on its tyrosine residues in prostate cancer
cells and further proved that Y1073, Y1112 and Y1176 of δ-catenin are
predominant sites responsible for tyrosine phosphorylation mediated
by c-Src. In addition to c-Src, Fgr, Fyn and Lyn were also found to phos-
phorylate δ-catenin. Furthermore, c-Src-mediated Tyr-phosphorylation
of δ-catenin was found to increase its stability via decreasing its afﬁnity
to GSK3β and enhance its ability of inducing nuclear distribution of
β-catenin through interrupting the integrity of the E-cadherin complex.
2. Materials and methods
2.1. Plasmids
The constructs of δ-catenin wild type (WT), ΔN85-325, 1-1040 in
pEGFP-C1 have been previously described [43]. The deletion constructs
of 1-690, 690-1040, 1-1070, 1-1140, 1-1170 and 1-1120were generated
by PCR ampliﬁcation and cloned into pEGFP-C1 vector. The construction
of mutants Y1176F, Y1179F, Y1189F, Y1176/1179/1189F, Y1073(1-
1140), Y1112F(1-1140) and Y1121F(1-1140) was generated by site-
directed mutagenesis. The constructs of pCMV5 RF-Src [dominant-
negative (K295R, Y527F)] and Src were kindly provided by Joan Brugge
(Harvard Medical School). The constructs of HM-Fyn, HM-Fgr and MH-
Lyn were generously gifted by Nacksung Kim (Chonnam National
University).
2.2. Antibodies
Antibodies were purchased from commercial companies as follows:
anti-δ-catenin (#611537), anti-E-cadherin (#610182, BD Bioscience);
anti-GFP (#G1544), anti-β-actin (#A5441), anti-β-catenin (#C2206),
and anti-α-tubulin (#T9026, Sigma), anti-lamin B (SC-6216), anti-
py20 (SC-508) and anti-E-cadherin (SC-7080, Santa Cruz); anti-Src
(#05-184), anti-Fyn (#4023), anti-Fgr (#2755), anti-Lyn (#2732),
anti-myc (#2276) and anti-GSK3α/β(#5676, Cell Signaling). HA
epitope was detected using media from 12CA5 hybridoma.
2.3. Cell culture and transfection
MEF,NIH/3T3 and Bosc23 cellswere cultured in DMEMsupplement-
ed with 10% FBS and 1% penicillin/streptomycin at 37 °C with 5% CO2.
CWR22Rv-1 (Human prostate cancer cell line) cells were grown in
RPMI supplemented with 10% FBS and 1% penicillin/streptomycin at
37 °C with 5% CO2. Rv/δ and Rv/C cells derived from CWR22Rv-1, over-
expressing δ-catenin and GFP respectively, were maintained in RPMI
supplemented with 10% FBS, 1% penicillin/streptomycin and G418
(Sigma, St Louis, MO) 125 μg/ml at 37 °C with 5% CO2.
Bosc23 cells were transfected using calcium phosphate while other
cells were transfected using Lipofectamine Plus reagent (Invitrogen,
Carlsbad, CA) according to the manufacturer's instructions.2.4. Sodium orthovanadate treatment
Sodium orthovanadate obtained from Sigma was dissolved in dis-
tilled water to make a stock concentration of 20 mM. The stock solution
of sodium orthovanadate was added into warm media to make a ﬁnal
concentration of 40 μM followed by gentle mixing. Following this, the
media in the culture dishes were replaced with the media containing
sodium orthovanadate and cells were kept in this media for 24 h.
2.5. Immunoblotting and immunoprecipitation
Immunoblotting and immunoprecipitation were performed as pre-
viously described [28]. Lysates were incubated with primary antibodies
for 16 h at 4 °C and pulled outwith protein G sepharose (GE healthcare,
Uppsala, Sweden) for 3 h. The immunoprecipitated proteins were elut-
ed at 95 °C for 2 min with 15 μl of 2× sample buffer (0.1 M Tris–HCl,
pH6.8, 0.2 M DTT, 4% SDS, 20% glycerol, 0.2% bromophenol blue,
1.43 M β-mercaptoethanol) and analyzed by immunoblotting.
2.6. Puriﬁcation of cell surface proteins by biotinylation
Biotinylation was performed as previously described [23]. Brieﬂy,
transfected Rv/δ and Rv/C cells were cultured in 100 mm dishes and
were collected to perform further experiment when cells' density was
near conﬂuence. Speciﬁcally, cells were gently washed and collected
in 1.5 microcentrifuge tubes using ice-cold reaction buffer (0.1 M phos-
phate, 0.15 M NaCl, pH 8.0). Cell surface proteins were labeled with Bi-
otin by incubating the tubes with 0.5 mM Sulfo-NHS-SS-Biotin (Pierce,
Rockford, IL) at room temperature for 30 min. Next, the cells were
lysed in MLB lysis buffer followed by centrifugation at 13,200 rpm for
15 min at 4 °C. After measuring the protein concentration of each sam-
ple, equal amounts of protein lysates were explored to pull-down with
streptavidin-agarose beads (Pierce, Rockford, IL). This process resulted
in puriﬁcation of the membrane proteins. Next, the puriﬁed proteins
were subjected to immunoblotting. The biotinylated plasmamembrane
localized E-cadherin was then detected by immunoblotting with an
E-cadherin antibody.
2.7. Cell fractionation
The Subcellular Protein Fractionation Kit for Cultured Cells (78840,
Thermo Scientiﬁc) was explored to separate cytoplasmic, membrane
and nuclear protein extracts. Brieﬂy, cells were harvested with
trypsin-EDTA and centrifuged at 500 ×g for 5 min. The supernatant
was then removed carefully, and the cell pellets were washed with
PBS followed by centrifugation at 500 ×g for 2–3 min. The supernatant
was discarded carefully again to leave cell pellets as dry as possible.
Next, speciﬁc buffers in the Kit were added into the tubes containing
the cell pellets in certain order according to the protocol.
Protein extracts from different compartments of cells were subject-
ed to immunoblotting. Lamin B antibody was used as a nuclear protein
markerwhileα-tubulin antibody and E-cadherin antibodywere used as
cytoplasmic and membrane protein markers, respectively.
2.8. Primary cortical neurons culture and siRNA transfection
Cortical neuronswere prepared fromE14 C57BL/6 embryos (Daehan
Biolink, Daejeon, Korea). Cerebral cortices were removed from the
embryos, partially dissociated in PBS and incubated with 0.25% trypsin
in HBSS for 20 min at 37 °C. The trypsin was inactivated by adding
FBS (Gibco, Gaithersburg,MD) and the tissuewas trituratedwith a ster-
ile constricted Pasteur pipette. Cortical neurons were seeded at
1 × 106 cells/well in 24-well plates pre-coated with 100 μg/ml poly-D-
lysine (Sigma, St. Louis, MO). Cortical neurons were maintained in
Neurobasal Media (Invitrogen, Carlsbad, CA) supplemented with B27
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CO2 atmosphere.
After culturing cortical neurons for 2 days, control siRNA (Cell sig-
naling, 6568S) and speciﬁc anti-Src siRNA (SC-29228) were transfected
into these cells. After 72 h of the transfection, the cells were harvested
to perform western blot.
2.9. In vitro kinase assay
The Src kinase assay kit (17-131, Upstate biotechnology) was
explored to perform in vitro kinase assay with puriﬁed proteins from
immunoprecipitation. Brieﬂy, Bosc23 cells were transiently transfected
with δ-catenin-GFP and harvested after 24 h of transfection. Next,
protein lysate were subjected to immunoprecipitation. The immune
complexes were washed three times with lysis buffer and once with
Src kinase reaction buffer (Catalog #20-121) and then incubated for
10 min at 30 °C with agitation in a reaction mixture supplemented
with c-Src kinase (Catalog# 14-117) protein and 10 μCi of [γ-32P] ATP.
The reactions were stopped by adding SDS sample buffer. The phos-
phorylation status of δ-catenin was determined by autoradiography.
3. Results
3.1. δ-Catenin can be mainly phosphorylated on its tyrosine residues on its
C-terminus by Src kinase and other SFKs, including Fgr, Fyn and Lyn
To study tyrosine phosphorylation of δ-catenin, a stable CWR22Rv-1
cell line overexpressing mouse GFP-δ-catenin was established and
designated as Rv/δ. Another stable CWR22Rv-1 cell line overexpressing
GFP was established as a control cell line, designated as Rv/C (Fig. 1A).
Immunoblotting and immunoprecipitation were performed with these
two cell lines. Phosphorylated δ-catenin by tyrosine kinases was
observed by immunoprecipitation with anti-py20 antibody followed
by immunoblotting with anti-GFP antibody. Speciﬁc phosphorylated
δ-catenin could be observed in Rv/δ cells under the treatment of sodium
orthovanadate (Fig. 1A).
To investigate which region of δ-catenin is mainly responsible for
Tyr-phosphorylation, δ-catenin and its two deletion constructs were
transfected into Bosc23 cells. We found that the Tyr-phosphorylation
of δ-catenin could be dramatically impaired when the 207 amino acids
at the C-terminus of δ-catenin were deleted (Fig. 1B). In order to con-
ﬁrm the necessity of C-terminus in Tyr-phosphorylation of δ-catenin,
two δ-catenin deletion mutants, 1-690 and 691-1040 were transfected
into Bosc23 cells. Immunoprecipitation data showed that 1-690,Fig. 1. Tyr-phosphorylation of δ-catenin is observed in CWR22Rv-1 cells as well as in Bosc23 c
terminus of δ-catenin. (A) Tyr-phosphorylation of δ-catenin in Rv/δ cells. Rv/C and Rv/δ cells w
spectively. They were cultured in media containing 40 μM sodium orthovanadate for 24 h. N: n
was observed by immunoprecipitationwith anti-py20 antibody followed by immunoblottingw
lysatewas subjected to immunoblotting analysis to show the input level of eachprotein (left pan
illustration of constructs of GFP-δ-catenin WT and its different deletions (N terminal deletion:
Bosc23 cellswere transfectedwith GFP-δ-cateninWT, N-terminal deletion and C-terminal delet
of 40 μM for 24 h. After harvesting cells, the cell lysates were subjected to immunoprecipitatioN-terminus of δ-catenin, could be much less phosphorylated compared
to FL and that 691-1040, which is part of 10 arm repeats of δ-catenin
missing both N-terminus and C-terminus, could be scarcely phosphory-
lated (Fig. S1). Taken together, these results indicate that tyrosine
residues in the C-terminus of δ-catenin can be phosphorylated by
tyrosine kinases compared to other parts of δ-catenin.
One previous report demonstrated that Src family kinases Fyn could
phosphorylate δ-catenin on its tyrosine residues in PC-12 cells [27].
Here, we co-transfected δ-catenin eitherwithwild type c-Src or its inac-
tive form RF-Src into Bosc23 cells to see if c-Src kinase itself can phos-
phorylate δ-catenin in epithelial cells. As shown in Fig. 2A, c-Src kinase
can phosphorylate δ-catenin on its tyrosine residues in a dosage depen-
dentmanner, but RF-Src failed to do the same, indicating that in fact the
kinase domain of c-Src is necessary for c-Src-mediated phosphorylation
of δ-catenin. Next, we examined if c-Src mainly phosphorylates
δ-catenin on its C-terminus since C-terminus of δ-catenin is necessary
for its tyrosine phosphorylation according to the results in Fig. 1B. As
shown in Fig. 2B, deletion of C-terminus of δ-catenin signiﬁcantly
impaired c-Src-mediated Tyr-phosphorylation on δ-catenin while dele-
tion of N-terminus of δ-catenin had no negative effects on it, suggesting
that C-terminus of δ-catenin is necessary for c-Src-mediated phosphor-
ylation. To check whether c-Src could phosphorylate δ-catenin in vitro,
we performed Src kinase assay. As shown in Fig. 3, c-Src can phosphor-
ylate δ-catenin in vitro.
Src family kinases can be divided into two subfamilies: the Src
subfamily and the Lyn subfamily. Here, we tested if other members in
these two main subfamilies can phosphorylate δ-catenin as c-Src does.
As shown in Fig. 2C, Fgr, Fyn and Lyn can phosphorylate δ-catenin to dif-
ferent extents in the order from high to low of Fgr, Fyn and Lyn.We also
investigated if the C-terminus of δ-catenin is necessary for the phos-
phorylation of δ-catenin mediated by Fgr, Fyn and Lyn as it is in c-Src-
mediated Tyr-phosphorylation. As shown in Fig. 2D, the C-terminus of
δ-catenin is important for Fgr-mediated Tyr-phosphorylation. A similar
pattern was observed in Tyr-phosphorylation of δ-catenin induced by
Fyn and Lyn (data not shown). In summary, these data suggest that
the C-terminus of δ-catenin can be phosphorylated by Src family
kinases.
3.2. Y1073, Y1112 and Y1176 are identiﬁed as three of major sites that can
be phosphorylated by c-Src
To further narrow down the region on δ-catenin that is Tyr-
phosphorylated by c-Src, several C-terminal deletion mutants were
made and transfected into Bosc23 cells. We found that the mutantsells, and a signiﬁcant decrease in phosphorylation level is found in the absence of the C-
ere derived from CWR22Rv-1 cells, overexpressing either GFP or mouse GFP-δ-catenin, re-
o treatment; SV: sodium orthovanadate treatment. The Tyr-phosphorylation of δ-catenin
ithGFP antibody (right upper panel) and py20 antibody (right bottompanel). 10 μg of each
els). (B) Tyr-phosphorylation of δ-catenin in Bosc 23 cells. Upper panel: the representative
85-325 was deleted; C terminal deletion 1-1040:1041-1247 was deleted). Bottom panel:
ion. Sodiumorthovanadatewas added into the culturemedia tomake a ﬁnal concentration
n with anti-py20 antibody followed by immunoblotting with anti-GFP antibody.
Fig. 2. Src family kinases phosphorylate δ-cateninmainly on its C-terminus. (A) c-Src phosphorylates δ-catenin in a dosage dependentmanner. Bosc23 cellswere transfectedwith different
combinations of plasmids as follows: GFP-δ-catenin only; GFP-δ-catenin and different amounts of RF-Src (kinase inactive form); GFP-δ-catenin and different amounts of c-Src. The lysates
were collected to perform immunoprecipitation with anti-py20 antibody followed by immunoblotting with anti-δ-catenin, anti-Src and anti-β-actin antibodies. Protein expression was
checked by immunoblotting (left panels). (B) Bosc23 cells were transfectedwith different combinations of plasmids as follows: c-Src andGFP-δ-cateninWT; c-Src andN-terminal deletion
of GFP-δ-catenin; c-Src and C-terminal deletion of GFP-δ-catenin. The lysateswere subjected to immunoprecipitationwith anti-py20 antibody followed by immunoblottingwith anti-GFP,
anti-c-Src and anti-β-actin antibodies. Protein expression was checked by immunoblotting (left panels). (C) Fgr, Fyn and Lyn kinases can phosphorylate δ-catenin on its C-terminus.
Bosc23 cells were transfected with different combinations of plasmids, as follows: GFP-δ-catenin only; GFP-δ-catenin and MH-Fgr; GFP-δ-catenin and MH-Fyn; GFP-δ-catenin and MH-
Lyn. After 24 h of transfection, the cells were harvested, and the cell lysates were subjected to immunoprecipitation with anti-py20 antibody followed by immunoblotting with anti-δ-
catenin antibody. (D) Fgr can phosphorylate δ-catenin on its C-terminus. Bosc23 cells were transfected with different combinations of plasmids, as follows: GFP-δ-catenin; GFP-δ-
catenin and MH-Fgr; N-terminal deletion of GFP-δ-catenin and MH-Fgr; C-terminal deletion of GFP-δ-catenin (1-1040: numbers indicate amino acids that the mutant contains) and
MH-Fgr. The cell lysates were explored for immunoprecipitation with anti-py20 antibody followed by immunoblotting with anti-GFP (δ-catenin) antibody.
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phosphorylated by c-Src, whereas the mutants 1-1200 and 1-1140
did not show the same pattern (data not shown). This ﬁnding indi-
cates that the region of 1071-1140 and of 1171-1200 contains the
main tyrosine residues necessary for the occurrence of phosphoryla-
tion. In order to conﬁrm this, immunoprecipitation was performed
with anti-py20 antibody followed by immunoblotting with anti-δ-
catenin antibody. As expected, the data were in agreement with
the observation that 1071-1140 and 1171-1200 contain the most
potential tyrosine residues that can be phosphorylated by c-Src
(Fig. 4A). Interestingly, we observed a speciﬁc ~50 KD fragmentFig. 3. c-Src can phosphorylate δ-catenin in vitro. Puriﬁed δ-catenin-GFP from immunoprecipita
The other two were exposed to [γ-32P] ATP either without or with Src kinase. Puriﬁed GFP from
sidered as a positive control in the kinase assay.and a speciﬁc ~90 KD fragment in CWR22Rv-1 cells overexpressing
1-1170 and in CWR22Rv-1 cell overexpressing 1-1070, respectively
(Fig. 4B).
Since the region of 1171-1200 contains three tyrosine residues,
Y1176, Y1179 and Y1189, we made point mutants Y1176F, Y1179F,
Y1189F and Y1176/79/89F to mapwhich residue among them is neces-
sary for c-Src-mediated Tyr-phosphorylation of δ-catenin (Fig. 4C, left
panel). Interestingly, all mutants showed less Tyr-phosphorylation to
some extent in Bosc23 cells overexpressing c-Src. However, compared
to Tyr-phosphorylation of δ-catenin WT, the decreases in the level of
Tyr-phosphorylation of Y1176F and of Y1176/79/89F were much moretion was divided into three parts equally. One was used as input showing in bottom panel.
Immunoprecipitation was used as a negative control whereas puriﬁed P120ctn was con-
Fig. 4. Y1073, Y1112 and Y1176 aremajor sites for tyrosine phosphorylation of δ-cateninmediated by c-Src. (A) The regions 1071–1140 and 1171–1200 of δ-catenin contain tyrosine sites
for phosphorylation induced by c-Src. Bosc23 cells were transfected with different combinations of plasmids as follows: GFP-δ-catenin WT; GFP-δ-catenin + c-Src: 1-1200;
1-1200 + c-Src; 1–1170; 1-1170 + c-Src; 1-1140; 1-1140 + c-Src; 1-1070; 1-1070 + c-Src. The cells were harvested, and protein expression in transfected cells was checked by immu-
noblotting with anti-δ-catenin, anti-c-Src ad anti-β-actin antibodies. Following this, the cell lysates were used to perform immunoprecipitation with anti-py20 antibody followed by
immunoblotting with anti-δ-catenin antibody. (B) Deletion mutants of δ-catenin generated speciﬁc fragments in CWR22Rv-1 cells. CWR22Rv-1 cells were transfected as follows:
GFP-δ-catenin WT, 1-1200, 1-1170, 1-1140 and 1-1070. The cells were harvested, and the cell lysates were subjected to immunoblotting with anti-GFP antibody. (C) The representative
illustration of the constructs of δ-catenin point mutants. Left panel: δ-catenin point mutants made by GFP-δ-catenin WT: Y1176F, Y1179F, Y1189F and Y1176/79/89F. Right panel:
δ-catenin point mutants made by 1-1140 (GFP-δ-catenin deletion mutant): Y1073F, Y1112F and Y1121F. (D) The Y1073F, Y1112F and Y1176F can be less phosphorylated by c-Src. Left
panel: Bosc23 cells cultured in different dishes were transfected with GFP-δ-catenin WT and its mutants either in the presence of exogenous c-Src or in the absence of exogenous
c-Src. After transfection for 24 h, the cells were harvested, and the cell lysates were subjected to immunoblotting with anti-δ-catenin and immunoprecipitation with anti-py20 antibody
followed by immunoblotting with anti-δ-catenin. The density of protein bandswasmeasured byMulti Gauge v3.1 software. The numbers above the upper panel represent relative values
of the protein density of Yp-δ-catenin to protein density of δ-catenin. Right panel: Bosc23 cells were transfected with GFP-δ-catenin deletion (1-1140) and its point mutant counterparts
either in the presence of c-Src overexpression or in the absence of c-Src overexpression. After transfection for 24 h, the cells were harvested, and the cell lysates were subjected to immu-
noprecipitationwith anti-py20 antibodies followed by immunoblottingwith anti-δ-catenin antibody (middle panel). The basal expression of δ-cateninwas check by immunoblottingwith
anti-δ-catenin antibody. The density of protein bands wasmeasured byMulti Gauge v3.1 software. The numbers above the upper panel represent relative values of the protein density of
Yp-δ-catenin to protein density of δ-catenin.
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indicates that Y1176 is one of the main tyrosine residues in the region
of 1171-1200 necessary for Tyr-phosphorylation of δ-catenin induced
by c-Src.
C-Src could strongly phosphorylate the mutant 1-1140 but failed to
do the samewith themutant 1-1070 (Fig. 4A), indicating that the region
of 1071-1140 contains potential tyrosine residues that can bephosphor-
ylated by c-Src. In order to map which residue is necessary for c-Src-
mediated Tyr-phosphorylation of 1-1140, we further made several
point mutants, Y1073F, Y1112F and Y1121F using 1-1140 as a template
(Fig. 4C, right panel). In comparison to 1-1140, a decrease of Tyr-
phosphorylation by c-Src could be observed from all point mutants in
transient transfected Bosc23 cells. However, the extent of decrease var-
ied among thesemutants in the order fromhigh to low: Y1073F, Y1112F
and Y1121F (Fig. 4D, right panel). This ﬁnding suggests that Y1073 andY1112 are two of themain tyrosine residues in the region of 1071-1140
necessary for Tyr-phosphorylation of δ-catenin induced by c-Src.
Taken together, these results suggest that Y1073, Y1112 and Y1176
are three of major sites necessary for Tyr-phosphorylation of δ-catenin
induced by c-Src.
3.3. C-Src-mediated Tyr-phosphorylation of δ-catenin increases its protein
level and stability
To investigate how c-Src-mediated Tyr-phosphorylation affects
δ-catenin, we ﬁrst checked the protein expression of δ-catenin either
in the presence of exogenous c-Src or in the absence of exogenous
c-Src in Bosc23 cells. Interestingly, we found that the protein level of
δ-catenin was dramatically increased in the presence of c-Src overex-
pression in Bosc23 cells (Fig. 5A). We also observed the same pattern
Fig. 5. c-Src-mediated Tyr-phosphorylation of δ-catenin increases its protein expression and stability. (A) c-Src overexpression increases protein expression of δ-catenin. Transfection of
GFP-δ-catenin and c-Src was performed in Bosc23 cells. The cells were harvested, and the cell lysates were subjected to immunoblotting to check protein expression with speciﬁc anti-
bodies as indicated. (B) The Src kinase inhibitor, SU6656, decreased the protein expression of both δ-catenin and Tyr-phosphorylated δ-catenin. GFP-δ-catenin and c-Src were co-
transfected into Bosc23 cells. After transfection for 24 h, a speciﬁc Src kinase inhibitor, SU6656, was added into the culture media. The cells were maintained in this media containing
10nMSU6656 for 24 h before being harvested. The cell lysateswere used to perform immunoblotting to check the protein expression of δ-catenin, Src andβ-actin andwere also subjected
to immunoprecipitation with anti-py20 antibody followed by immunoblotting with anti-δ-catenin antibody. (C) c-Src affects endogenous δ-catenin protein expression. Primary mouse
embryonic cortical neurons were isolated from mouse embryos. siRNAs were transfected into cells at the day 2 of isolation. After transfection for 72 h, the primary cells were harvested
to perform immunoblotting. Primary neurons were also treated with SU6656 10 nM for 24 h before being harvested. The cell lysates were subjected to immunoblotting. (D) c-Src in-
creased the protein stability of δ-catenin. Upper panel: MEF (GSK3β+/+) cells were transfected either with GFP-δ-catenin and c-Src or with GFP-δ-catenin and GFP. After transfection
for 12 h, the cellswere treatedwith cycloheximide 50 μMfor different time durations as indicated. The cell lysateswere collected and subjected to immunoblotting. Bottompanel: Relative
value of protein level of δ-catenin. Protein density in immunoblotting was measured by Multi Gauge, and the protein level of δ-catenin was normalized by protein level of β-actin. The
experiment was repeated three times and the average and standard deviations are shown.
763Y. He et al. / Biochimica et Biophysica Acta 1843 (2014) 758–768in MEF and Rv/δ cells (Fig. S2A). To conﬁrm that the increased δ-catenin
expression is induced by c-Src, we treated Bosc23 cells overexpressing
δ-catenin and c-Src and Rv/δ cells with SU6656, a speciﬁc Src family ki-
nase inhibitor. The protein level of δ-catenin and of phosphorylated
δ-catenin was decreased in both cell lines (Figs. 5B, S2B). To investigate
whether c-Src affects endogenous δ-catenin, we performed knockdown
experiment in primarymouse embryonic cortical neurons by using spe-
ciﬁc anti-Src-siRNA. Endogenous δ-catenin protein expression was dra-
matically decreased in cells transfected anti-Src-siRNA compared to that
in cells transfected with control-siRNA (Fig. 5C, upper panel). We have
also treated the primary neuronswith SU6656, the pattern is consistent
with siRNA experiment (Fig. 5C bottom panel). Taken together, these
results suggest that c-Src-mediated Tyr-phosphorylation of δ-catenin
can enhance the protein level of δ-catenin.
To examine if c-Src increases the δ-catenin protein level through en-
hancing its stability, we tested the protein half-life of δ-catenin in MEF
cells by treating δ-catenin transfected cells with cycloheximide for dif-
ferent time durations. We observed that the half-life of δ-catenin was
around 12 h in cells expressing both exogenous c-Src and δ-catenin,
whereas its half-life was only around 6 h in cells expressing both exog-
enousGFP and δ-catenin (Fig. 5D). Thisﬁnding indicates that c-Src over-
expression increases δ-catenin stability.
3.4. C-Src-mediated Tyr-phosphorylation of δ-catenin increases its protein
stability through decreasing the interaction between δ-catenin and GSK3β
We previously reported that GSK3β phosphorylates δ-catenin
and negatively regulates its stability via ubiquitination/proteosome-mediated proteolysis [29]. Li, Y et al. demonstrated that c-Src decreases
the interaction of MUC1 and GSK3β [30]. Therefore, we investigated to
ﬁnd out whether the mechanism underlying stabilization of δ-catenin
by c-Src is that c-Src can interfere with the interaction between
δ-catenin and its negative regulator GSK3β. To verify this hypothesis,
we overexpressed δ-catenin and c-Src in WT MEF (GSK3β+/+) and
GSK3β null MEF (GSK3β−/−) cells. In consistent with what we ob-
served previously [29], total protein expression of δ-catenin was much
higher in GSK3β null MEF cells than that inWTMEF cells due to the ab-
sence of GSK3β in null cells. However, interestingly, the extent of in-
creased δ-catenin level by c-Src in WT MEF cells was higher than that
in GSK3β null cells (Fig. 6A), suggesting that c-Src is more capable of
protecting δ-catenin from negative regulation by GSK3β than that by
other unknown factors. To further conﬁrm this notion, we performed
an immunoprecipitation experiment in Bosc23 cells with both anti-
δ-catenin and anti-HA antibody. As shown in Fig. 6B, HA-GSK3β-
immuno complexes were analyzed by immunoblotting with anti-δ-
catenin antibody. The results demonstrate that c-Src decreases the
interaction of δ-catenin to GSK3β. Reverse immunoprecipitation
showed a similar pattern (bottom panel). To examine if c-Src decreases
the interaction between δ-catenin and GSK3β through c-Src mediated
Tyr-phosphorylation of δ-catenin, we compared the negative effects of
c-Src and RF-Src on the interaction. The results showed that the interac-
tion between δ-catenin and GSK3βwas decreased in cells overexpress-
ing c-Src while it was not in cells overexpressing RF-Src (Fig. 6C), which
is in consistent withwhat we observed in Fig. 6B.We also tested if c-Src
induced Tyr-phosphorylation of δ-catenin can protect δ-catenin from
ubiquitination/proteosome-mediated proteolysis. As shown in Fig. 6D,
Fig. 6. C-Src can stabilize δ-catenin through interrupting the interaction between δ-catenin andGSK3β (A)MEF (GSK3β+/+) andMEF (GSK3β−/−) cells were transfected eitherwith GFP-δ-
catenin or with GFP-δ-catenin and c-Src together. The cell lysates from the transfected cells were subjected to immunoblotting. Each sample was triplicated, and the number above the upper
panel represents the relative density of δ-catenin protein to the density of β-actin protein. (B) Bosc23 cells were transfectedwith different combinations of plasmids as follows: GFP-δ-catenin,
GSK3β-HA and c-Src; GFP-δ-catenin, GSK3β-HA andGFP. The cellswere harvested after 48 h of transfection, and the cell lysateswere subjected to immunoblottingwith the following antibod-
ies: anti-δ-catenin, anti-GSK3α/β, anti-Src, anti-py20 and anti-β-actin antibody. After checking protein expression in the cell lysates, immunoprecipitation experiments were performed with
either anti-HA antibody or δ-catenin antibody followed by immunoblotting with antibody as indicated (two bottom panels). (C) Bosc23 cells were transfected with different combinations of
plasmids as follows: GFP-δ-catenin, GSK3β-HA and c-Src; GFP-δ-catenin, GSK3β-HA and RF-Src. The cell lysates were subjected to immunoblotting with the following antibodies: anti-δ-
catenin, anti-HA, anti-Src and anti-β-actin antibody. The cell lysates then were used to perform immunoprecipitation with anti-HA followed by immunoblotting with anti-δ-catenin and
anti-HA antibodies (right panels). (D) Bosc23 cells were transfected with different combinations of plasmids as follows: GFP-δ-catenin, Ubi-HA and c-Src; GFP-δ-catenin, Ubi-HA and RF-Src.
The cell lysates were subjected to immunoblotting with the following antibodies: anti-δ-catenin, anti-Src, anti-py20 and anti-HA. The cell lysates were then used to perform immunoprecip-
itation with either anti-HA or anti-δ-catenin followed by immunoblotting with either anti-δ-catenin or anti-HA antibodies, respectively (right panels).
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than that in the presence of RF-Src. Taken together, these results sug-
gest that c-Src-mediated Tyr-phosphorylation of δ-catenin decreases
the interaction between δ-catenin and GSK3β and therefore protects
δ-catenin from ubiquitination led by GSK3β-mediated phosphorylation
on T1078 of δ-catenin.3.5. Stabilized δ-catenin by c-Src-mediated Tyr-phosphorylation increases
its ability of enhancing nuclear distribution of β-catenin through disturbing
the integrity of the E-cadherin
Previously, we demonstrated that one of δ-catenin's biological func-
tions is to induce E-cadherin processing and thereby increase nuclear
Fig. 7. Tyr-phosphorylation of δ-catenin mediated by c-Src increases its ability of enhancing nuclear distribution of β-catenin through disturbing the integrity of the E-cadherin. (A) E-
cadherin processing in both Rv/δ and Rv/C cells when either RF-Src or c-Src overexpressed. Both Rv/δ and Rv/C cells were transfectedwith either RF-Src or c-Src and subjected to fraction-
ation experiment. The membrane fractions were subjected to immunoblotting with anti-E-cadherin (BD). (B) The interaction between E-cadherin and β-catenin was dramatically more
decreased in Rv/δ cells than it was in Rv/C cells in the presence of overexpressed c-Src. Both Rv/δ and Rv/C cells were transfectedwith either RF-Src or c-Src. The cells were harvested, and
the lysates were used to perform immunoblotting with the following antibodies: anti-δ-catenin, anti-β-actin, anti-E-cadherin and anti-β-catenin antibody. After checking protein expres-
sion, the cell lysates were subjected to immunoprecipitation with anti-E-cadherin antibody (SC) followed by immunoblotting with anti-β-catenin antibody. (C) Both Rv/δ and Rv/C cells
were transfected with either RF-Src or c-Src and subjected to fractionation experiment. Protein expression of β-catenin in each lysate was measured by immunoblotting. α-tubulin and
lamin B were used as cytoplamic and nuclear markers, respectively. The density of β-catenin was measured. The numbers above the upper panel represent relative values of β-catenin
normalized by either α-tubulin or lamin B.
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Tyr-phosphorylation of δ-catenin affects its known oncogenic function.
To this end, we performed a series of experiments in Rv/δ cells. In
order to rule out the possibility that the patterns we observed
were caused by c-Src-mediated Tyr-phosphorylation on other
proteins, such as E-cadherin, β-catenin and so forth, we explored
Rv/C cells as control. We ﬁrst checked E-cadherin processing in
the presence of overexpression of either c-Src or RF-Src in both
cell lines. As shown in Fig. 7A, the fragment pattern of E-cadherin
processing was signiﬁcantly changed when c-Src was overex-
pressed in Rv/δ cells. The fragment whose size was around 75 KD
decreased whereas the fragment whose size was around either 50
KD or 60 KD increased. The fragment pattern of E-cadherin process-
ing was also slightly changed in Rv/C cells when c-Src was over-
expressed. However, it was not as signiﬁcant as that in Rv/δ cells
and the pattern of 75 KD fragment showed differently. These results
indicate that both δ-catenin and c-Src can affect E-cadherin process-
ing but in a different manner. In order to conﬁrm this pattern, we
also performed transient transfection of both δ-catenin and c-Src
in the CWR22Rv-1 cell line. The results from both fractionation
and biotinylation are consistent with what we found in Rv/C and
Rv/δ cells (Fig. S3).We next tested whether c-Src-mediated Tyr-phosphorylation of
δ-catenin affects nuclear distribution of β-catenin. As shown in Fig. 7B,
the binding afﬁnity of β-catenin to E-cadherin was decreased when
c-Src was overexpressed. However, such decrease in afﬁnity was
muchmore dramatic in Rv/δ cells than that in Rv/C cells. In order to ex-
amine if the releasedβ-catenin undergoes degradation or enters the nu-
cleus, we next performed a fractionation experiment. As shown in
Fig. 7C, the nuclear distribution of β-catenin was increased in both cell
lines. However, the enhancement of distributionwasmuchmore signif-
icant in Rv/δ cells than that in Rv/C cells. Taken together, the above re-
sults indicate that Tyr-phosphorylation of δ-catenin mediated by c-Src
increases its ability of enhancing the nuclear distribution of β-catenin
via interrupting the integrity of the E-cadherin.4. Discussion
The current study primarily demonstrates that: 1) δ-catenin can be
phosphorylated by c-Src on its Y1073, Y1112 and Y1176 and also by
Fgr, Fyn and Lyn on its C-terminus; 2) the Tyr-phosphorylation of
δ-catenin by c-Src enhances its stability via decreasing the binding of
δ-catenin to GSK3β; 3) the Tyr-phosphorylation of δ-catenin increases
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interrupting the integrity of the E-cadherin.
Until now, we have made several attempts to identify the speciﬁc
tyrosine residues on δ-catenin that can be phosphorylated by Src kinase.
We found that the regions of 1071-1140 and 1171-1200 contain the
major tyrosine sites for c-Src-mediated Tyr-phosphorylation by making
four different C-terminal deletion mutants. However, it is difﬁcult to in-
terpret why deletion of the region between them, namely, the region of
1141-1170, dramatically increases the level of phosphorylation com-
pared to either deletion of 1071-1140 or of 1171-1200. There are two
possible explanations for this interesting puzzle. One is that deletion
may signiﬁcantly change the secondary structure of the C-terminus
causing various conformations that have speciﬁc preferences for c-Src
phosphorylation. The other is that the region of 1141-1170 on
δ-catenin can bind to speciﬁc inhibitory proteins that can protect the
potential tyrosine sites in 1071-1140 from being phosphorylated by
c-Src, such as phosphatases. We cannot determine which one of these
explanations is in fact true. Furthermore, according to our data from im-
munoprecipitation to py20 antibody, c-Src can phosphorylate δ-catenin
on Y1073, Y1112, Y1176 and Y1179, with the predominant sites being
Y1073, Y1112 and Y1176. However, the pathophysiological function of
c-Src phosphorylation on these sites has not been discovered yet. More-
over, although our data showed that c-Src phosphorylated δ-catenin
mainly on its C-terminus, we cannot rule out the possibility that c-Src
may phosphorylate δ-catenin on other tyrosine residues than Y1073,
Y1112 and Y1176 on C-terminus or tyrosine sites in other regions to
mediate its critical biological functions in different microenvironments.
Identifying all the tyrosine sites on δ-catenin and the relative functions
of each site would take great time and effort. Themostwell studied pro-
tein in the catenin family of armadillo proteins is β-catenin. It was dis-
covered that Y64, Y86, Y142, Y331, Y333, Y 489, Y654 and Y670 can be
phosphorylated on β-catenin by various tyrosine kinases showing dif-
ferent functions in various environments. However, these discoveries
have been found by different scientiﬁc groups over several years
[31–37]. Another instance is p120ctn. Eight tyrosine sites on the
N-terminus of p120ctn have been identiﬁed to be phosphorylated by
Src [38]. However, the functional consequences of each speciﬁc modiﬁ-
cation have not been fully elucidated. In this study, we pointed out three
major tyrosine sites of δ-catenin that can be phosphorylated by c-Src.
Although we did not discover the biological roles they may play, our
ﬁndings provide new insights into a better understanding of tyrosine
phosphorylation of δ-catenin to build the foundation for future studies
about tyrosine phosphorylation of δ-catenin.
Next, we investigated how c-Src-mediated phosphorylation affects
the level of δ-catenin. Interestingly, we found that c-Src can increase
the stability of δ-catenin in MEF cells. The potential mechanism could
be that c-Src-mediated phosphorylation decreases the binding afﬁnity
of δ-catenin to its negative regulators. Two negative regulators of
δ-catenin have been identiﬁed: PS-1 and GSK3β [29,39]. Therefore,
there are three potential mechanisms underlying our observation that
c-Src stabilizes δ-catenin: 1) c-Src decreases the turnover of δ-catenin
induced by PS-1; 2) c-Src protects δ-catenin from being phosphorylated
by GSK3β; and 3) c-Src affects the regulation controlled by both regula-
tors. Even though we could not rule out the possibility that there are
other negative regulators apart from PS-1 and GSK3β, we examined
all three possibilities mentioned above in this study. Interestingly,
c-Src could reduce the binding of δ-catenin to GSK3β but failed to signif-
icantly affect its afﬁnity to PS-1 (data not shown). Li YQ et al. reported
that c-Src-mediated phosphorylation of MUC1/CD is associated with a
decrease in the binding of MUC1/CD and GSK3β [30]. Our ﬁnding that
Src kinase can change δ-catenin's afﬁnity to GSK3β is consistent with
what LI YQ et al. found about the relationship between c-Src and
GSK3β. Moreover, these interesting ﬁndings led to a possible pattern
of protein regulation in which a protein can be positively regulated
by c-Src and negatively regulated by GSK3β. We found that the
C-terminus of δ-catenin is necessary for tyrosine phosphorylationinduced by c-Src. Therefore, there are two possibilities resulted in this
observation. One is that c-Src and GSK3β competes to bind to δ-
catenin. The other is that c-Src Tyr-phosphorylates δ-catenin at its C-
terminus, which in turn, changes its conformational structure to lower
the binding afﬁnity to GSK3β.
We also determined how c-Src-mediated Tyr-phosphorylation of
δ-catenin affects its biological function. We previously discovered that
δ-catenin increases the nuclear distribution of β-catenin through
interrupting E-cadherin integrity [23]. In the current study, we found
that stabilization of δ-catenin by Tyr-phosphorylation increases this
ability. Both p120ctn and δ-catenin are known to bind to the
juxtamembrane domain of E-cadherin. However, their functions are dif-
ferent. P120ctn has been known to stabilize E-cadherin through com-
petitively binding to the juxtamembrane domain of E-cadherin where
it contains residues that can be phosphorylated by Src kinase followed
by Hakai mediated ubiquitination [40], whereas δ-catenin has been re-
ported to promote E-cadherin processing which, in turn, increases the
nuclear distribution of β-catenin, and subsequently activating target
genes expression [23]. Tyrosine phosphorylation of p120ctn has been
found to affect its localization. And p120ctn remains unphosphorylated
when it binds to microtubules or when it resides in the cytoplasm of
cadherin-deﬁcient cells [41,42]. However, no signiﬁcant changes in
p120ctn/E-cadherin association were found even when p120ctn was
strongly phosphorylated in v-Src transfected cells or upon RTK stimula-
tion [9]. Here, we failed to see the changes of δ-catenin protein expres-
sion in either the membrane or cytoplasm. However, interestingly, we
were able to observe Tyr-phosphorylated δ-catenin at a detectable
level in membrane fractionation but not in cytoplasmic fractionation
(data not shown). Moreover, we failed to observe any drastic changes
in δ-catenin afﬁnity to E-cadherin in the presence of c-Src overexpres-
sion (data not shown).
In addition to c-Src, we demonstrated that other Src family kinases,
including Fgr, Fyn and Lyn, can phosphorylate δ-catenin. Interestingly,
we observed that different kinases showed various abilities of phos-
phorylating δ-catenin. More speciﬁcally, Lyn showed the lowest ability
to phosphorylate δ-catenin among them. This may result from different
kinases' structures. SFKs can be classiﬁed into two subfamilies on the
basis of overall homology. One is the Lyn subfamily containing Lyn,
Hck, Lck and Blk. The other is the Src subfamily including Src, Yes, Fyn
and Fgr. Although all these kinases belong to SFKs, Lyn's structure is to
some degree different from Fyn and Fgr [2]. Therefore, the difference
in structuremay be the reason for Lyn's lower ability of phosphorylating
δ-catenin.
δ-Catenin has been found to be overexpressed in prostate cancer,
and thus is considered as a new potential bio-marker for the detection
of prostate cancer. However, how it is involved in tumor progression
is not yet fully understood. In the current study, we linked δ-catenin
to Src, a novel potential target for prostate cancer treatment. Speciﬁcal-
ly, we found that δ-catenin can be phosphorylated by c-Src, Fgr, Fyn and
Lyn. Phosphorylation of δ-catenin by c-Src can increase its stability and
enhance its ability tomodulate E-cadherin processing aswell as nuclear
localization of β-catenin (Fig. 8). In summary, the current study adds
new insights into how post-translational modiﬁcation of δ-catenin af-
fects its stability and function in prostate cancer, thereby increasing
the potential predictive value of δ-catenin for prostate cancer.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2013.12.021.
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Fig. 8. Schematic diagram illustrating the role of c-Src-induced phosphorylation of δ-catenin in increasing its stability through decreasing its afﬁnity to GSK3β and in enhancing its ability of
promoting E-cadherin processing and nuclear distribution of β-catenin.
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